Introduction: People living with HIV (PLWHIV) are exposed to Metabolic Syndrome (MS), which increases their risk of having cardiovascular events and type 2 diabetes. No data on this subject is available in Togo. Objective: The objective of our study was to make an inventory of the metabolic syndrome among PLWHIV in Togo. Method: This was a prospective cross-sectional descriptive and analytical study on PLWHIV received at the day hospital of the Infectious Diseases Department of the Sylvanus Olympio University Hospital for a period of six months. Results: A total of 279 PLWHIV patients were enrolled, of which 237 (84.9%) were on Highly Active Antiretroviral Treatment (HAART) and 42 (15.1%) were naive. Metabolic syndrome has been demonstrated in 28.7% of the study population. Abdominal obesity was the most represented component of MS with a proportion of 57.7%. Risk factors associated with MS were female sex (OR = 3.01; CI: 1.52 - 5.93; p < 0.001), body mass index ≥ 25 Kg/m2 (OR = 3.29; CI: 1.92 - 5.64; p < 0.001), HDL hypocholesterolemia (OR = 12.24; CI: 5.78 - 25.89; p < 0.001), hypertriglyceridemia (OR = 5.09; CI: 2.40 - 10.79; p < 0.01), hyperglycemia (OR = 3.39; CI: 1.82 - 6.30; p < 0.024), LDL hypercholesterolemia (OR = 2.04; CI: 1.17 - 3.56; p < 0.012), CD4 count ≥ 500 cel/mm3 (OR = 1.85; CI: 1.06 - 3.20; p < 0.029), high blood pressure (OR = 13.04; CI: 6.16 - 27.62; p < 0.001). Conclusion: There is a need to screen MS for PLWHIV so that risk factors associated with it can be addressed early.
(n.d.) Global HIV & AIDS Statistics—2019 Fact Sheet.
https://www.unaids.org/en/resources/fact-sheet
[3]
Masuku, S.K., Tsoka-Gwegweni, J. and Sartorius, B. (2019) HIV and Antiretroviral Therapy-Induced Metabolic Syndrome in People Living with HIV and Its Implications for Care: A Critical Review. Journal of Diabetology, 10, 41-47.
https://doi.org/10.4103/jod.jod_21_18
[4]
Caballero, A.E. (2004) Endothelial Dysfunction, Inflammation, and Insulin Resistance: A Focus on Subjects at Risk for Type 2 Diabetes. Current Diabetes Reports, 4, 237-246. https://doi.org/10.1007/s11892-004-0074-9
[5]
Dooko, C.B.A., Wit, S.D., Neuhaus, J., Palfreeman, A., Pepe, R., Pankow, J.S., et al. (2014) Interleu-kin-6, High Sensitivity C-Reactive Protein, and the Development of Type 2 Diabetes among HIV-Positive Patients Taking Antiretroviral Therapy. Journal of Acquired Immune Deficiency Syndromes, 67, 538-546.
https://doi.org/10.1097/QAI.0000000000000354
[6]
De Larranaga, G., Petroni, A., Deluchi, G., Alonso, B. and Benetucci, J. (2003) Viral Load and Disease Progression as Responsible for Endothelial Activation and/or Injury in Human Immunodeficiency Virus-1-Infected Patients. Blood Coagulation & Fibrinolysis: An International Journal in Haemostasis and Thrombosis, 14, 15-18.
https://doi.org/10.1097/00001721-200301000-00004
[7]
Harrington, L., Hatton, R., Mangan, P., Turner, H., Murphy, T., Murphy, K., et al. (2005) Interleukin 17-Producing CD4+ Effector T Cells Develop via a Lineage Distinct from the T Helper Type 1 and 2 Lineages. Nature Immunology, 6, 1123-1132.
https://doi.org/10.1038/ni1254
[8]
Carr, M.C. and Brunzell, J.D. (2004) Abdominal Obesity and Dyslipidemia in the Metabolic Syndrome: Importance of Type 2 Diabetes and Familial Combined Hyperlipidemia in Coronary Artery Disease Risk. The Journal of Clinical Endocrinology & Metabolism, 89, 2601-2607. https://doi.org/10.1210/jc.2004-0432
[9]
Worm, S.W. and Lundgren, J.D. (2011) The Metabolic Syndrome in HIV. Best Practice & Research Clinical Endocrinology & Metabolism, 25, 479-486.
https://doi.org/10.1016/j.beem.2010.10.018
Moukaila, A.R., Bawe, L.D., Mossi, E.K., Patassi, A.A., Tsevi, Y.M., Nemi, K.D., et al. (2019) Dyslipidemia in People Living with HIV on Anti-Retroviral Treatment: Case of the Ambulatory Treatment Center (ATC) of the Sylvanus Olympio University Hospital of Lome. Open Journal of Internal Medicine, 9, 141-157.
https://doi.org/10.4236/ojim.2019.94019
[12]
Alberti, K.G.M.M., Eckel, R.H., Grundy, S.M., Zimmet, P.Z., Cleeman, J.I., Donato, K.A., et al. (2009) Harmonizing the Metabolic Syndrome: A Joint Interim Statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation, 120, 1640-1645.
https://doi.org/10.1161/CIRCULATIONAHA.109.192644
[13]
Samaras, K., Wand, H., Law, M., Emery, S., Cooper, D. and Carr, A. (2007) Prevalence of Metabolic Syndrome in HIV-Infected Patients Receiving Highly Active Antiretroviral Therapy Using International Diabetes Foundation and Adult Treatment Panel III Criteria: Associations with Insulin Resistance, Disturbed Body Fat Compartmentalization, Elevated C-Reactive Protein, and [Corrected] Hypoadiponectinemia. Diabetes Care, 30, 113-119. https://doi.org/10.2337/dc06-1075
[14]
Alvarez, C., Salazar, R., Galindez, J., Rangel, F., Lopardo, G., et al. (2010) Metabolic Syndrome in HIV-Infected Patients Receiving Antiretroviral Therapy in Latin America. Brazilian Journal of Infectious Diseases, 14, 256-263.
https://doi.org/10.1016/S1413-8670(10)70053-2
[15]
Tiozzo, E., Konefal, J., Adwan, S., Martinez, L.A., Villabona, J., Lopez, J., et al. (2015) A Cross-Sectional Assessment of Metabolic Syndrome in HIV-Infected People of Low Socio-Economic Status Receiving Antiretroviral Therapy. Diabetology & Metabolic Syndrome, 7, 15. https://doi.org/10.1186/s13098-015-0008-5
[16]
Bosho, D.D., Dube, L., Mega, T.A., Adare, D.A., Tesfaye, M.G. and Eshetie, T.C. (2018) Prevalence and Predictors of Metabolic Syndrome among People Living with Human Immunodeficiency Virus (PLWHIV). Diabetology & Metabolic Syndrome, 10, 10. https://doi.org/10.1186/s13098-018-0312-y
[17]
Katoto, P.D.M.C., Thienemann, F., Bulabula, A.N.H., Esterhuizen, T.M., Murhula, A.B., Lunjwire, P.P.M., et al. (2018) Prevalence and Risk Factors of Metabolic Syndrome in HIV-Infected Adults at Three Urban Clinics in a Post-Conflict Setting, Eastern Democratic Republic of the Congo. Tropical Medicine & International Health, 23, 795-805. https://doi.org/10.1111/tmi.13073
[18]
Dimodi, H.T., Etame, L.S., Nguimkeng, B.S., Mbappe, F.E., Ndoe, N.E., Tchinda, J.N., et al. (2014) Prevalence of Metabolic Syndrome in HIV-Infected Cameroonian Patients. World Journal of AIDS, 4, 85-92. https://doi.org/10.4236/wja.2014.41011
[19]
Hansen, B.R., Petersen, J., Haugaard, S.B., Madsbad, S., Obel, N., Suzuki, Y., et al. (2009) The Prevalence of Metabolic Syndrome in Danish Patients with HIV Infection: The Effect of Antiretroviral Therapy. HIV Medicine, 10, 378-387.
https://doi.org/10.1111/j.1468-1293.2009.00697.x
[20]
Wu, P.-Y., Hung, C.-C., Liu, W.-C., Hsieh, C.-Y., Sun, H.-Y., Lu, C.-L., et al. (2012) Metabolic Syndrome among HIV-Infected Taiwanese Patients in the Era of Highly Active Antiretroviral Therapy: Prevalence and Associated Factors. The Journal of Antimicrobial Chemotherapy, 67, 1001-1009. https://doi.org/10.1093/jac/dkr558
[21]
Muyanja, D., Muzoora, C., Muyingo, A., Muyindike, W. and Siedner, M.J. (2016) High Prevalence of Metabolic Syndrome and Cardiovascular Disease Risk among People with HIV on Stable ART in Southwestern Uganda. AIDS Patient Care and STDs, 30, 4-10. https://doi.org/10.1089/apc.2015.0213
[22]
Obirikorang, C., Quaye, L., Osei-Yeboah, J., Odame, E.A. and Asare, I. (2016) Prevalence of Metabolic Syndrome among HIV-Infected Patients in Ghana: A Cross-Sectional Study. Nigerian Medical Journal: Journal of the Nigeria Medical Association, 57, 86-90. https://doi.org/10.4103/0300-1652.182082
[23]
Mbunkah, H., Meriki, H., Anthony Tufon, K., Nfor, O. and Nkuo-Akenji, T. (2014) Prevalence of Metabolic Syndrome in Human Immunodeficiency Virus-Infected Patients from the South-West Region of Cameroon, Using the Adult Treatment Panel III Criteria. Diabetology & Metabolic Syndrome, 6, 92.
https://doi.org/10.1186/1758-5996-6-92
[24]
Todowede, O.O., Mianda, S.Z. and Sartorius, B. (2019) Prevalence of Metabolic Syndrome among HIV-Positive and HIV-Negative Populations in Sub-Saharan Africa—A Systematic Review and Meta-Analysis. Systematic Reviews, 8, 4.
https://doi.org/10.1186/s13643-018-0927-y
[25]
Villamar, M.F., Albuja, A.C. and Salas, N.I. (2011) Metabolic Syndrome among HIV-Infected Out-Patients from a Hospital in Quito, Ecuador: A Cross Sectionnal Study. Revista Panamericana Infectologia, 13, 12-18.
[26]
Tesfaye, D.Y., Kinde, S., Medhin, G., Megerssa, Y.C., Tadewos, A., Tadesse, E., et al. (2014) Burden of Metabolic Syndrome among HIV-Infected Patients in Southern Ethiopia. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 8, 102-107.
https://doi.org/10.1016/j.dsx.2014.04.008
[27]
Krishnan, S., Schouten, J., Atkinson, B., Brown, T., Wohl, D., McComsey, G., et al. (2012) Metabolic Syndrome before and after Initiation of Antiretroviral Therapy in Treatment-Naive HIV-Infected Individuals. Journal of Acquired Immune Deficiency Syndromes (1999), 61, 381-389.
https://doi.org/10.1097/QAI.0b013e3182690e3c
[28]
Mondy, K., Overton, E.T., Grubb, J., Tong, S., Seyfried, W., Powderly, W., et al. (2007) Metabolic Syndrome in HIV-Infected Patients from an Urban, Midwestern US Outpatient Population. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America, 44, 726-734.
https://doi.org/10.1086/511679
[29]
Samaras, K. (2009) Prevalence and Pathogenesis of Diabetes Mellitus in HIV-1 Infection Treated with Combined Antiretroviral Therapy. JAIDS Journal of Acquired Immune Deficiency Syndromes, 50, 499.
https://doi.org/10.1097/QAI.0b013e31819c291b
[30]
Dau, B. and Holodniy, M. (2008) The Relationship between HIV Infection and Cardiovascular Disease. Current cardiology Reviews, 4, 203-218.
https://doi.org/10.2174/157340308785160589
[31]
Jacobson, D., Tang, A., Spiegelman, D., Thomas, A., Skinner, S. and Wanke, C. (2007) Incidence of Metabolic Syndrome in a Cohort of HIV-Infected Adults and Prevalence Relative to the US Population (National Health and Nutrition Examination Survey). Journal of Acquired Immune Deficiency Syndromes (1999), 43, 458-466.
https://doi.org/10.1097/01.qai.0000243093.34652.41
[32]
Elgalib, A., Aboud, M., Kulasegaram, R., Dimian, C., Duncan, A., Wierzbicki, A.S., et al. (2011) The Assessment of Metabolic Syndrome in UK Patients with HIV Using Two Different Definitions: CREATE 2 Study. Current Medical Research and Opinion, 27, 63-69. https://doi.org/10.1185/03007995.2010.537212
[33]
Alencastro, P.R., Wolff, F.H., Oliveira, R.R., Ikeda, M.L.R., Barcellos, N.T., Brandao, A.B.M., et al. (2009) Metabolic Syndrome and Population Attributable Risk among HIV/AIDS Patients: Comparison between NCEP-ATPIII, IDF and AHA/NHLBI Definitions. AIDS Research and Therapy, 9, 29.
https://doi.org/10.1186/1742-6405-9-29
